| pubmed-article:10760767 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10760767 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:10760767 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
| pubmed-article:10760767 | lifeskim:mentions | umls-concept:C0021756 | lld:lifeskim |
| pubmed-article:10760767 | lifeskim:mentions | umls-concept:C0927232 | lld:lifeskim |
| pubmed-article:10760767 | lifeskim:mentions | umls-concept:C0007134 | lld:lifeskim |
| pubmed-article:10760767 | lifeskim:mentions | umls-concept:C2709248 | lld:lifeskim |
| pubmed-article:10760767 | lifeskim:mentions | umls-concept:C0040053 | lld:lifeskim |
| pubmed-article:10760767 | lifeskim:mentions | umls-concept:C0027627 | lld:lifeskim |
| pubmed-article:10760767 | lifeskim:mentions | umls-concept:C1302234 | lld:lifeskim |
| pubmed-article:10760767 | lifeskim:mentions | umls-concept:C1521761 | lld:lifeskim |
| pubmed-article:10760767 | lifeskim:mentions | umls-concept:C0205390 | lld:lifeskim |
| pubmed-article:10760767 | lifeskim:mentions | umls-concept:C1948023 | lld:lifeskim |
| pubmed-article:10760767 | lifeskim:mentions | umls-concept:C1533148 | lld:lifeskim |
| pubmed-article:10760767 | pubmed:issue | 8 | lld:pubmed |
| pubmed-article:10760767 | pubmed:dateCreated | 2000-5-10 | lld:pubmed |
| pubmed-article:10760767 | pubmed:abstractText | Interleukin-2 (IL-2) and granulocyte-macrophage-colony stimulating factor (GM-CSF) are cytokines with nonoverlapping pleiotropic effects. In a prior Phase Ib study, this combination of agents exhibited antitumor effects in the lungs of four of eight patients with renal cell carcinoma and pulmonary metastases. We conducted this Phase Ib/II trial to determine the response rate of renal cell carcinoma patients with pulmonary metastases treated with continuous infusion IL-2 plus GM-CSF. | lld:pubmed |
| pubmed-article:10760767 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10760767 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10760767 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10760767 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10760767 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10760767 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:10760767 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10760767 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10760767 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10760767 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:10760767 | pubmed:issn | 0008-543X | lld:pubmed |
| pubmed-article:10760767 | pubmed:author | pubmed-author:CHUT STS | lld:pubmed |
| pubmed-article:10760767 | pubmed:author | pubmed-author:HandJ HJH | lld:pubmed |
| pubmed-article:10760767 | pubmed:author | pubmed-author:AlbertiniMM | lld:pubmed |
| pubmed-article:10760767 | pubmed:author | pubmed-author:WildingGG | lld:pubmed |
| pubmed-article:10760767 | pubmed:author | pubmed-author:LarsonMM | lld:pubmed |
| pubmed-article:10760767 | pubmed:author | pubmed-author:SchillerJ HJH | lld:pubmed |
| pubmed-article:10760767 | pubmed:author | pubmed-author:SondelPP | lld:pubmed |
| pubmed-article:10760767 | pubmed:author | pubmed-author:SalamatM SMS | lld:pubmed |
| pubmed-article:10760767 | pubmed:author | pubmed-author:HorionCC | lld:pubmed |
| pubmed-article:10760767 | pubmed:author | pubmed-author:KhorsandMM | lld:pubmed |
| pubmed-article:10760767 | pubmed:copyrightInfo | Copyright 2000 American Cancer Society. | lld:pubmed |
| pubmed-article:10760767 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10760767 | pubmed:day | 15 | lld:pubmed |
| pubmed-article:10760767 | pubmed:volume | 88 | lld:pubmed |
| pubmed-article:10760767 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10760767 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10760767 | pubmed:pagination | 1892-901 | lld:pubmed |
| pubmed-article:10760767 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:10760767 | pubmed:meshHeading | pubmed-meshheading:10760767... | lld:pubmed |
| pubmed-article:10760767 | pubmed:meshHeading | pubmed-meshheading:10760767... | lld:pubmed |
| pubmed-article:10760767 | pubmed:meshHeading | pubmed-meshheading:10760767... | lld:pubmed |
| pubmed-article:10760767 | pubmed:meshHeading | pubmed-meshheading:10760767... | lld:pubmed |
| pubmed-article:10760767 | pubmed:meshHeading | pubmed-meshheading:10760767... | lld:pubmed |
| pubmed-article:10760767 | pubmed:meshHeading | pubmed-meshheading:10760767... | lld:pubmed |
| pubmed-article:10760767 | pubmed:meshHeading | pubmed-meshheading:10760767... | lld:pubmed |
| pubmed-article:10760767 | pubmed:meshHeading | pubmed-meshheading:10760767... | lld:pubmed |
| pubmed-article:10760767 | pubmed:meshHeading | pubmed-meshheading:10760767... | lld:pubmed |
| pubmed-article:10760767 | pubmed:meshHeading | pubmed-meshheading:10760767... | lld:pubmed |
| pubmed-article:10760767 | pubmed:meshHeading | pubmed-meshheading:10760767... | lld:pubmed |
| pubmed-article:10760767 | pubmed:meshHeading | pubmed-meshheading:10760767... | lld:pubmed |
| pubmed-article:10760767 | pubmed:meshHeading | pubmed-meshheading:10760767... | lld:pubmed |
| pubmed-article:10760767 | pubmed:meshHeading | pubmed-meshheading:10760767... | lld:pubmed |
| pubmed-article:10760767 | pubmed:meshHeading | pubmed-meshheading:10760767... | lld:pubmed |
| pubmed-article:10760767 | pubmed:meshHeading | pubmed-meshheading:10760767... | lld:pubmed |
| pubmed-article:10760767 | pubmed:meshHeading | pubmed-meshheading:10760767... | lld:pubmed |
| pubmed-article:10760767 | pubmed:meshHeading | pubmed-meshheading:10760767... | lld:pubmed |
| pubmed-article:10760767 | pubmed:meshHeading | pubmed-meshheading:10760767... | lld:pubmed |
| pubmed-article:10760767 | pubmed:year | 2000 | lld:pubmed |
| pubmed-article:10760767 | pubmed:articleTitle | A phase Ib/II trial of granulocyte-macrophage-colony stimulating factor and interleukin-2 for renal cell carcinoma patients with pulmonary metastases: a case of fatal central nervous system thrombosis. | lld:pubmed |
| pubmed-article:10760767 | pubmed:affiliation | Department of Medicine, University of Wisconsin, Madison, Wisconsin 53792, USA. | lld:pubmed |
| pubmed-article:10760767 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:10760767 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:10760767 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:10760767 | pubmed:publicationType | Research Support, U.S. Gov't, Non-P.H.S. | lld:pubmed |
| pubmed-article:10760767 | pubmed:publicationType | Case Reports | lld:pubmed |
| pubmed-article:10760767 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:10760767 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
| pubmed-article:10760767 | pubmed:publicationType | Clinical Trial, Phase I | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10760767 | lld:pubmed |
